Satellos Bioscience Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -5,963 | -6,366 | -6,478 | -3,292 |
EBIT | -5,966 | -6,367 | -6,479 | -3,300 |
Net Income | -5,821 | -5,608 | -6,141 | -3,300 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,129 | -4,846 | -7,366 | -4,695 |
Cash | 19,304 | 38,217 | 32,712 | 40,175 |
Basic Shares | 13,944 | 14,268 | 13,818 | 13,818 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -94 | |||
EBITDA | -19,564 | -11,838 | -8,090 | -11,258 |
EBIT | -19,578 | -11,843 | -8,338 | -11,388 |
Net Income | -19,578 | -11,977 | -8,342 | -12,161 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -17,406 | -8,746 | -4,263 | -3,953 |
Cash | 40,175 | 16,634 | 1,417 | 3,820 |
Basic Shares | 9,564 | 7,200 | 2,973 | 2,006 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.42 |
2025-06-30 | -$0.39 |
2025-03-31 | -$0.44 |
2024-12-31 | -$0.31 |